| Literature DB >> 31316652 |
Sally A F El-Sahrigy1, Mohamed G Shouman1, Hanan M Ibrahim2, Azza M O Abdel Rahman1, Sonia Adolf Habib1, Aser A Khattab3, Howayda E Gomaa1, Naiven A Helmy1.
Abstract
BACKGROUND: Hospital-acquired (nosocomial) infection is a common serious health problem worldwide, especially in pediatric intensive care units and is associated with high mortality and morbidity, prolonged hospital stays and high cost. AIM: To determine the types of organisms involved in hospital-acquired an infection in two pediatric intensive care units during the one-year study and its anti-microbial susceptibility.Entities:
Keywords: Anti-microbial; Egypt; Hospital-acquired infection; Pediatric ICU
Year: 2019 PMID: 31316652 PMCID: PMC6614260 DOI: 10.3889/oamjms.2019.485
Source DB: PubMed Journal: Open Access Maced J Med Sci ISSN: 1857-9655
Culture results among studied patients
| Culture/Organism | Blood No % | Endobronchial No % | Urine No % | Skin No % | Total No infection % |
|---|---|---|---|---|---|
| No growth | 50 76 | 44 67 | 58 88 | 55 83.5 | |
| Gram +ve cocci | |||||
| Staph | 8 12 | 3 4.5 | 0 0 | 4 6 | 15 |
| Strept | 0 0 | 1 1.5 | 1 1.5 | 0 0 | 26.3 |
| Gram -ve bacilli | 2 3.5 | ||||
| Klebsiella | 2 3 | 8 12 | 1 1.5 | 1 1.5 | |
| Acinetobacter | 4 6 | 4 6 | 4 6 | 2 3 | 12 21 |
| E. coli | 1 1.5 | 2 3 | 0 0 | 0 0 | 14 24.6 |
| Yersinia | 0 0 | 1 1.5 | 0 0 | 0 0 | 3 5.3 |
| Serratia | 0 0 | 1 1.5 | 0 0 | 2 3 | 1 1.7 |
| Enterobacter | 1 1.5 | 1 1.5 | 0 0 | 2 3 | 3 5.3 |
| Candida | 0 0 | 0 0 | 2 3 | 0 0 | 4 7 |
| Mixed | 0 0 | 1 1.5 | 0 0 | 0 0 | 2 3.5 1 1.7 |
| Total | 66 100 | 66 100 | 66 100 | 66 100 |
Antibiotic Sensitivity Among Studied Patients
| Organism/Antibiotic | Staph No: 15 | Strep No: 2 | Kleb No: 12 | Acinet-obacter No: 14 | E. coli No: 3 | Serratia No: 3 | Yersenia No: 1 | Entero No: 4 | Candida No: 2 |
|---|---|---|---|---|---|---|---|---|---|
| Amoxaclav | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Amikacin | 11 | 0 | 6 | 6 | 0 | 0 | 1 | 3 | 0 |
| Imipenam | 9 | 0 | 2 | 6 | 0 | 1 | 1 | 3 | 0 |
| Cephalosporin | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 |
| Ciprofloxacillin | 3 | 1 | 5 | 3 | 0 | 1 | 0 | 2 | 0 |
| Gentamycin | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
| Piperacillin | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Tobramycin | 1 | 0 | 4 | 2 | 1 | 0 | 0 | 1 | 0 |
| Vancomycin | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Seasonal variation of infectious organisms in studied patients
| Season | No of patients | Blood culture +ve | Endobronchial culture +ve | Urine culture +ve | Skin culture +ve |
|---|---|---|---|---|---|
| Spring | 16 | 2 | 5 | 4 | 3 |
| Summer | 15 | 5 | 6 | 0 | 5 |
| Autumn | 11 | 1 | 4 | 1 | 2 |
| Winter | 24 | 8 | 7 | 3 | 1 |
| Total | 66 | 16 | 22 | 8 | 11 |
Risk estimate for infections among studied patients
| Infections | Survival N (%) | Non-Survival N (%) | Fisher’s exact test p-value | |
|---|---|---|---|---|
| Staph | Negative | 34 (81%) 8 (19%) | 18 (75%) 6 (25%) | 0.755 NS |
| Positive | ||||
| Klebsiella | Negative | 34 (81%) 8 (19%) | 22 (91.7%) 2 (8.3%) | 0.306 NS |
| Positive | ||||
| Nosocomial infection | Negative | 18 (42.9%) 24 (57.1) | 8 (33.3%) 16 (66.7%) | 0.601 NS |
| Positive | ||||
| Pneumonia and Sepsis | Negative | 24 (57.1%) 18 (42.9%) | 11 (54.2%) 13 (45.8%) | 0.448 NS |
| Positive |
Risk estimate for other risk factors including labs and invasive techniques among studied patients as a whole and in both groups
| Risk Factors | All patients (66) | Group 1 (31) | Group 2 (35) | |||
|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | Odds ratio | 95% CI | Odds ratio | 95% CI | |
| Anemia | 2.059 | 0.743-5.703 | 3.536 | 0.78-16.032 | 1.167 | 0.277-4.913 |
| Thrombocytopenia | 1.5 | 0.518-4.345 | 0.471 | 0.095-2.337 | 4.56 | 0.975-21.322 |
| Renal impairment | 5.857 | 0.574-59.808 | 0.379 | 0.238-0.604 | 2.3 | 0.130-40.545 |
| CVP | 1.667 | 0.599-4.641 | 1.018 | 0.235-4.407 | 2.45 | 0.562-10.68 |
| Urinary Catheter | 1.273 | 0.462-3.503 | 0.429 | 0.099-1.857 | 3.733 | 0.788-17.684 |
| Mechanical ventilation | 8.726 | 0.4698-162.064 | ||||
CI = Confidence Interval; CVP = Central Venous Line.
Descriptive data of patients under study
| Characteristic | PICU patients |
|---|---|
| Age (months) | 20.7 ± 25.8 |
| Sex (M/F) | 37/29 |
| Hb (gm/l) | 9.94 ± 1.65 |
| WBCs (x1000) | 13.28 ± 5.85 |
| Platelets (x1000) | 241.4 ± 143.18 |
| Urea (mg/dl) | 27.3 ± 24.5 |
| Creatinine (mg/dl) | 0.5 ± 0.69 |
| SGOT (mg/dl) | 135.64 ± 524.68 |
| SGPT (mg/dl) | 95.52 ± 329.3 |
| CRP | Positive for all patients |
| Period of PICU stay | 15.2 ± 13.94 |